BlogFriends in high places: Releaf joins the cannabis industry council

Friends in high places: Releaf joins the cannabis industry council

2 min read

Lucy MacKinnon

Friends in high places: Releaf joins the cannabis industry council
Here at Releaf we are delighted to announce that we have joined the ranks of one of the UK's leading membership organisations for the cannabis industry: The Cannabis Industry Council (CIC).

As the UK's only all-in-one medical cannabis subscription service, we are enthused to be working alongside over 100 other stakeholders within the CIC to advance the medical cannabis industry and empower patients. 

With members representing each link in the entire cannabis supply chain, the CIC unites charities, clinical groups, and research bodies to revolutionise the industry.

Offering participation in working groups, representation within the government, training courses, as well as events attendance and networking, The Cannabis Industry Council acts as a collective voice to campaign for change.

Commenting on the collaboration, our CEO and Founder Mason Soiza said: 

"We are thrilled to be joining The Cannabis Industry Council. By uniting with like-minded organisations, we can collectively drive positive change in the medical cannabis landscape.

Our vision aligns with the CIC's mission to enhance responsible access to cannabis, improve patient outcomes, and contribute to the industry's health, environmental, and economic benefits." 

Mike Morgan-Giles, The Cannabis Industry Council's CEO, mirrored this excitement commenting: 

"We are delighted to welcome Releaf to the Cannabis Industry Council. Their decision to join highlights how the CIC is becoming increasingly recognised across the sector.

"The medical cannabis sector faces a range of regulatory and policy challenges, and we look forward to Releaf contributing to developing solutions in the interests of the sector."

Here at Releaf, we are passionate about removing the stigma that surrounds medical cannabis in the UK and are dedicated to maintaining a seamless service for our patients by providing their prescribed medications with clarity and compassion.

Our innovative approach allows patients to utilise our comprehensive online platform to simplify the process, offering a convenient and secure way to acquire, consume, and benefit from medicinal cannabis. Accessing medical cannabis can be challenging due to the stigma surrounding it. However, Releaf makes it simple with our tailored monthly packages, specialist consultations for medical cannabis, and a unique medical cannabis card for protection, all based on a patients cannabis prescription.

It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.

Elevate your wellness with medical cannabis

Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.

Am I eligible?
Authors

With five years of journalism and healthcare content creation under her belt, Lucy strives to improve medical cannabis awareness and access in the UK by producing high quality, credible content.

Our articles are written by experts and reviewed by medical professionals or compliance specialists. Adhering to stringent sourcing guidelines, we reference peer-reviewed studies and scholarly research. View our editorial policy.


Further reading

How medical cannabis can play a role in palliative care

Decisions surrounding palliative care are something that almost all of us will face at some point in our lives, whether for ourselves or for someone we care deeply about. But before that time comes, it's a subject that is often avoided or at least slightly misunderstood.

Sam North

Schizophrenia Awareness Day: Understanding the exclusions in medical cannabis treatments

Every year, the 25th of July commemorates National Schizophrenia Awareness Day - an event established by mental health charity, Rethink Mental Health. The day aims to shine a spotlight on the everyday challenges faced by the millions of people living with schizophrenia and the stigma and discrimination that still remain around this diagnosis.

Emily Ledger